This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
CBD (Cannabidiol)
CBD is a non-psychoactive cannabinoid from the cannabis plant with significant anxiolytic, neuroprotective, and anti-inflammatory properties. It modulates the endocannabinoid system, serotonin receptors, and GABA signalling to reduce anxiety, improve sleep, and protect brain health.
Benefits
What is CBD (Cannabidiol)?
Cannabidiol (CBD) is one of over 100 cannabinoids found in the cannabis plant (Cannabis sativa). Unlike THC (tetrahydrocannabinol), CBD is non-psychoactive - it does not produce a "high" or impair cognitive function. In fact, CBD appears to counteract some of THC's psychoactive effects and has its own distinct therapeutic profile.
CBD has rapidly become one of the most widely used natural supplements worldwide, driven by growing research demonstrating benefits for anxiety, sleep disorders, chronic pain, epilepsy, and neurological health. The FDA approved the CBD-based drug Epidiolex in 2018 for treatment-resistant epilepsy, validating its pharmacological significance.
As a nootropic, CBD is primarily valued for its anxiolytic effects - reducing social anxiety, generalised anxiety, and stress-related cognitive impairment. It also shows neuroprotective potential through anti-inflammatory, antioxidant, and neurogenesis-promoting mechanisms. Unlike benzodiazepines, CBD reduces anxiety without sedation, cognitive impairment, or dependency.
- 5-HT1A receptor agonism: CBD directly activates serotonin 5-HT1A receptors, which mediate anxiolytic, antidepressant, and anti-nausea effects - this is likely the primary mechanism for its anxiety-reducing properties.
- Endocannabinoid modulation: Inhibits FAAH (fatty acid amide hydrolase), the enzyme that breaks down anandamide - the body's own "bliss molecule." This elevates endocannabinoid tone without directly activating CB1/CB2 receptors.
- GABA modulation: Acts as a positive allosteric modulator at GABA-A receptors, enhancing inhibitory neurotransmission and contributing to calming effects.
- Neurogenesis: Promotes hippocampal neurogenesis (new neuron formation) through multiple signalling pathways, which may underlie its antidepressant and memory-supportive effects.
- Anti-neuroinflammation: Reduces microglial activation and pro-inflammatory cytokine production, protecting neurons from chronic inflammatory damage.
- Antioxidant: Directly neutralises free radicals and reduces oxidative stress in neural tissue.
- For anxiety: 25–75 mg per day (clinical studies used 300–600 mg for acute anxiety, but lower daily doses show benefit)
- For sleep: 25–75 mg taken 30–60 minutes before bed
- For general wellness: 10–25 mg per day
- Bioavailability: Oral CBD has approximately 6–13% bioavailability. Sublingual oils improve absorption. Take with fatty food to enhance uptake.
- Onset: 30–90 minutes orally; 15–30 minutes sublingually
- Important: Start low (10–15 mg) and increase gradually. Individual responses vary significantly.
- Side effects: Generally well-tolerated. Possible fatigue, diarrhoea, changes in appetite, or dry mouth.
- Drug interactions: CBD inhibits CYP3A4 and CYP2C19 liver enzymes, which can affect the metabolism of many medications. Consult a doctor if taking other medications, especially blood thinners, antiepileptics, or immunosuppressants.
- Liver: High doses (>300 mg/day) may elevate liver enzymes. Monitor liver function with long-term high-dose use.
- THC content: Full-spectrum products may contain trace THC (<0.2% in UK, <0.3% in US). Use broad-spectrum or isolate if drug-tested.
- Pregnancy: Not recommended - insufficient safety data.
- Legal status: Legal in most countries when derived from hemp with THC below legal thresholds. Prescription-only as Epidiolex for epilepsy.
Natural Sources & Forms
- Hemp plant: Industrial hemp (Cannabis sativa with <0.2% THC in UK) is the primary source
- Product types: Full-spectrum (contains other cannabinoids + trace THC), broad-spectrum (THC removed), and CBD isolate (pure CBD)
- Delivery methods: Oils/tinctures (sublingual), capsules, gummies, topicals, and vape liquids. Sublingual oils offer the best balance of bioavailability and convenience.
Research Studies
Frequently Asked Questions
CBD is a non-psychoactive cannabinoid from the cannabis plant with significant anxiolytic, neuroprotective, and anti-inflammatory properties. It modulates the endocannabinoid system, serotonin receptors, and GABA signalling to reduce anxiety, improve sleep, and protect brain health.
The key benefits of CBD (Cannabidiol) include: Anxiety & Calm, Focus, Longevity, Mood, Sleep, Stress Relief.
5-HT1A receptor agonism: CBD directly activates serotonin 5-HT1A receptors, which mediate anxiolytic, antidepressant, and anti-nausea effects - this is likely the primary mechanism for its anxiety-reducing properties. Endocannabinoid modulation: Inhibits FAAH (fatty acid amide hydrolase), the enzyme that breaks down anandamide - the body's own "bliss molecule." This elevates endocannabinoid tone without directly activating CB1/CB2 receptors. GABA modulation: Acts as a positive allosteric modulator at GABA-A receptors, enhancing inhibitory neurotransmission and contributing to calming effects. Neurogenesis: Promotes hippocampal neurogenesis (new neuron formation) through multiple signalling pathways, which may underlie its antidepressant and memory-supportive effects. Anti-neuroinflammation: Reduces microglial activation and pro-inflammatory cytokine production, protecting neurons from chronic inflammatory damage. Antioxidant: Directly neutralises free radicals and reduces oxidative stress in neural tissue.
For anxiety: 25–75 mg per day (clinical studies used 300–600 mg for acute anxiety, but lower daily doses show benefit) For sleep: 25–75 mg taken 30–60 minutes before bed For general wellness: 10–25 mg per day Bioavailability: Oral CBD has approximately 6–13% bioavailability. Sublingual oils improve absorption. Take with fatty food to enhance uptake. Onset: 30–90 minutes orally; 15–30 minutes sublingually Important: Start low (10–15 mg) and increase gradually. Individual responses vary significantly.
Side effects: Generally well-tolerated. Possible fatigue, diarrhoea, changes in appetite, or dry mouth. Drug interactions: CBD inhibits CYP3A4 and CYP2C19 liver enzymes, which can affect the metabolism of many medications. Consult a doctor if taking other medications, especially blood thinners, antiepileptics, or immunosuppressants. Liver: High doses (>300 mg/day) may elevate liver enzymes. Monitor liver function with long-term high-dose use. THC content: Full-spectrum products may contain trace THC (
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!